683 Capital Management »

Armata Pharmaceuticals shares owned by 683 Capital Management

Quarter-by-quarter ownership of Armata Pharmaceuticals (ARMP) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Armata Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Armata Pharmaceuticals held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Armata Pharmaceuticals by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 137k 10.24
2025-12-31 $878k 140k 6.28

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
NVIDIA Corporation Put Option (NVDA)
Capital One Financial (COF)
Alnylam Pharmaceuticals (ALNY)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Tesla Motors Put Option (TSLA)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Praxis Precision Medicines I Com New Put Option (PRAX)
Wave Life Sciences SHS (WVE)
Becton, Dickinson and (BDX)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Armata Pharmaceuticals

Madison Asset Management
Vanguard Capital Management
Vanguard Group
Millennium Management
683 Capital Management
Geode Capital Management
Edgewood Management
Sei Investments
Renaissance Technologies
Vanguard Fiduciary Trust
BlackRock
Eudaimonia Asset Management
Goldman Sachs Group
State Street Corporation
Bridgeway Capital Management

View all funds holding Armata Pharmaceuticals